CDK4 and neoplasm: In particular, co-amplification of MDM2 and CDK4 is more prevalent in the low-grade parosteal OS (67%) compared to high-grade classical OS (12%) (8), showing a correlation between amplification levels and tumor grading and progression in the former group (29).